Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice
Détails
ID Serval
serval:BIB_BF74D42C981E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice
Périodique
Memorias do Instituto Oswaldo Cruz
ISSN
0074-0276 (Print)
Statut éditorial
Publié
Date de publication
1994
Volume
89 Suppl 2
Pages
71-6
Notes
Journal Article
Research Support, Non-U.S. Gov't
Research Support, Non-U.S. Gov't
Résumé
Multiple antigen peptide systems (MAPs) allow the incorporation of various epitopes in to a single synthetic peptide immunogen. We have characterized the immune response of BALB/c mice to a series of MAPs assembled with different B and T cell epitopes derived from the Plasmodium vivax circumsporozoite (CS) protein. A B-cell epitope from the central repeat domain and two T-cell epitopes from the amino and carboxyl flanking regions were used to assembled eight different MAPs. An additional universal T cell epitope (ptt-30) from tetanus toxin protein was included. Immunogenicity in terms of antibody responses and in vitro T lymphocyte proliferation was evaluated. MAPs containing B and T cell epitopes induced high titers of anti-peptides antibodies, which recognized the native protein on sporozoites as determined by IFAT. The antibody specificity was also determined by a competitive inhibition assay with different MAPs. A MAP containing the B cell epitope (p11) and the universal epitope ptt-30 together with another composed of p11 and the promiscuous T cell epitope (p25) proved to be the most immunogenic. The strong antibody response and specificity for the cognate protein indicates that further studies designed to assess the potential of these proteins as human malaria vaccine candidates are warranted.
Mots-clé
Animals
Enzyme-Linked Immunosorbent Assay
Epitopes/immunology
Malaria/*immunology
Mice
Mice, Inbred BALB C
Peptides/*immunology
Plasmodium vivax/*immunology
Vaccines, Synthetic/immunology
Pubmed
Web of science
Création de la notice
24/01/2008 14:54
Dernière modification de la notice
20/08/2019 15:33